Catalyst
Slingshot members are tracking this event:
ZIOPHARM (ZIOP) to launch Phase 1 study of a viral-based CAR T-cell therapy for myeloid malignancies in 2016
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 28, 2017
Occurred Source:
http://ir.ziopharm.com/releasedetail.cfm?ReleaseID=1031586
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1 Study, Car-t, Myeloid Leukemia, Viral-based Car-t, Cd-33
